Galyan Bio, Inc.

At Galyan Bio we are focused on De Novo Drug Development. Our innovative medicines are backed by the power of AI.

Our fierce curiosity, combined with our expertise in neurology, genetics, and machine learning, drives us to gain deeper understanding into the biologic underpinnings of the diseases we aim to treat. Galyan Bio decentralizes innovation with technology, builds novel data-driven pipelines, and fuels cross-organizational collaborations at a molecular level so that we can identify new medicines with the potential to profoundly impact patients’ lives.